Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genetic-Ancestry Analysis on >93,000 Individuals Undergoing Expanded Carrier Screening Reveals Limitations of Ethnicity-Based Medical Guidelines

Kristjan E. Kaseniit, Imran S. Haque, James D. Goldberg, Lee P. Shulman, Dale Muzzey
doi: https://doi.org/10.1101/2019.12.21.19015578
Kristjan E. Kaseniit
1Myriad Women’s Health, South San Francisco, CA
MEng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imran S. Haque
2Recursion Pharmaceuticals, Salt Lake City, UT
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Goldberg
1Myriad Women’s Health, South San Francisco, CA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee P. Shulman
3Northwestern Feinberg School of Medicine, Chicago, IL
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dale Muzzey
1Myriad Women’s Health, South San Francisco, CA
4Myriad Laboratories, Inc., Salt Lake City, UT
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dale.muzzey@myriad.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose Despite strong association between genetic ancestry and carrier status, current carrier-screening guidelines recommend testing for a limited set of conditions based on a patient’s self-reported ethnicity, which conflates genetic and cultural factors.

Materials and Methods For 93,419 individuals undergoing a 96-gene expanded carrier screen (ECS), correspondence was assessed among carrier status, self-reported ethnicity, and a dual-component genetic ancestry (e.g., 75% African/25% European) calculated from sequencing data.

Results Self-reported ethnicity was an imperfect indicator of genetic ancestry, with 9% of individuals having >50% genetic ancestry from a lineage inconsistent with self-reported ethnicity. Self-reported ethnicity-based carrier-screening guidelines are incomplete, as several conditions not included in guidelines had similarly strong correlation between carrier rate and genetic ancestry as conditions included in screening guidelines. Limitations of self-reported ethnicity led to missed carriers in at-risk populations: for 10 ECS conditions, patients with intermediate genetic ancestry backgrounds—who did not self-report the associated ethnicity—had significantly elevated carrier risk. Finally, for seven of the 16 conditions included in current screening guidelines, most carriers were not from the population the guideline aimed to serve.

Conclusion To provide equitable reproductive care, guidelines should discontinue the use of ethnicity as a basis for determining which patients are appropriate for carrier screening and instead recommend pan-ethnic ECS.

Competing Interest Statement

KE Kaseniit, IS Haque, JD Goldberg, and D Muzzey are current or former employees of Myriad Women’s Health. IS Haque was a former employee of Freenome, Inc. and is currently employed by Recursion Pharmaceuticals.

Funding Statement

This research was funded by Myriad Genetics. No external funding was received.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be shared as permitted upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 27, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genetic-Ancestry Analysis on >93,000 Individuals Undergoing Expanded Carrier Screening Reveals Limitations of Ethnicity-Based Medical Guidelines
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genetic-Ancestry Analysis on >93,000 Individuals Undergoing Expanded Carrier Screening Reveals Limitations of Ethnicity-Based Medical Guidelines
Kristjan E. Kaseniit, Imran S. Haque, James D. Goldberg, Lee P. Shulman, Dale Muzzey
medRxiv 2019.12.21.19015578; doi: https://doi.org/10.1101/2019.12.21.19015578
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Genetic-Ancestry Analysis on >93,000 Individuals Undergoing Expanded Carrier Screening Reveals Limitations of Ethnicity-Based Medical Guidelines
Kristjan E. Kaseniit, Imran S. Haque, James D. Goldberg, Lee P. Shulman, Dale Muzzey
medRxiv 2019.12.21.19015578; doi: https://doi.org/10.1101/2019.12.21.19015578

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (576)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (183)
  • Emergency Medicine (330)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (696)
  • Epidemiology (11083)
  • Forensic Medicine (8)
  • Gastroenterology (619)
  • Genetic and Genomic Medicine (3154)
  • Geriatric Medicine (307)
  • Health Economics (560)
  • Health Informatics (2034)
  • Health Policy (860)
  • Health Systems and Quality Improvement (780)
  • Hematology (308)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2975)
  • Nursing (162)
  • Nutrition (460)
  • Obstetrics and Gynecology (588)
  • Occupational and Environmental Health (614)
  • Oncology (1547)
  • Ophthalmology (474)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (200)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (909)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2773)
  • Public and Global Health (5581)
  • Radiology and Imaging (1088)
  • Rehabilitation Medicine and Physical Therapy (629)
  • Respiratory Medicine (755)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (286)
  • Surgery (342)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)